USA flag logo/image

An Official Website of the United States Government

Advanced Absorbance Detection for the AUC

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
76266
Program Year/Program:
2005 / STTR
Agency Tracking Number:
GM074435
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Aviv Biomedical, Inc.
750 VASSAR AVE LAKEWOOD, NJ -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2005
Title: Advanced Absorbance Detection for the AUC
Agency: HHS
Contract: 1R41GM074435-01
Award Amount: $99,973.00
 

Abstract:

DESCRIPTION (provided by applicant): The purpose of this STTR is to produce a commercially available rapid-scan absorbance optical detection system for XLA/I analytical ultracentrifuges. The currently available absorbance optical system provided by the analytical ultracentrifuge manufacturer is not optimized for sedimentation velocity analysis, the most commonly used analytical ultracentrifugation (AUC) experimental method in biomedical research. AUC is becoming the method of choice for: 1) the analysis of interacting complex systems, 2) QA/QC of biopharmaceutical products, 3) the characterization of vaccines, 4) the characterization of particle size distributions of virus solutions, and 5) the development of drug formulations. The federal Food and Drug Administration increasingly recommends that protein biologics be characterized by sedimentation velocity. It is essential that the data acquisition and manipulation software be modernized to minimize the potential for serious errors in the analysis and interpretation of data. The current absorbance system is too slow, particularly compromising data analysis for viral and vaccine samples. Current software is unable to index the thousands of data files generated, and does not record experimental setup or protocol, operator identification, or changes in the instrument conditions during an experiment, all of which can lead to confusion and errors when analyzing the results. Overcoming these limitations will allow ultracentrifugation to be used for analysis of larger particles and more complicated interacting systems. A prototype rapid-scan absorbance system has been developed that addresses these issues with a retrofit for existing instruments and vastly improved data acquisition and manipulation software. Work funded by this proposal would bring the prototype to commercial grade and integrate the hardware and software with the recently released fluorescence detection optical system. This work has the support of the base instrument manufacturer, academic researchers and pharmaceutical scientists.

Principal Investigator:

Glen D. Ramsay
7323701300
GLEN@AVIVBIOMEDICAL.COM

Business Contact:

Rosemarie Arch
7323701300
rosemarie@avivbiomedical.com
Small Business Information at Submission:

Aviv Biomedical, Inc.
Aviv Biomedical, Inc. 750 Vassar Ave Lakewood, NJ 08701

EIN/Tax ID: 222308040
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Research Institution Information:
UNIVERSITY OF NEW HAMPSHIRE
OFFICE OF SPONSORED RESEARCH
SERVICE BUILDING
DURHAM, NH 03824
RI Type: Nonprofit college or university